检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Canakinumab as first-line biological therapy in still's disease and differences between the systemic and the chronicarticular courses: real-life experience from the international aida registry

A. Vitale,V. Caggiano,M. C. Maggio, G. Lopalco, G. Emmi, J. Sota,F. La Torre, P. Ruscitti, E. Bartoloni,G. Conti, C. Fabiani,I. Mattioli, C. Gaggiano,F. Cardinale, L. Dagna, C. Campochiaro,R. Giacomelli, A. Balistreri, K. Laskari, A. Tufan, G. Ragab,I. Almaghlouth, E. Wiesik-Szewczyk,R. M. Pereira,B. Frediani, F. Iannone,P. Sfikakis, L. Cantarini

ANNALS OF THE RHEUMATIC DISEASES（2023）

引用 0|浏览2
暂无评分
关键词
Inflammatory arthritides,Registries,bDMARD
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要